Nemus licenses synthetic cannabinoid production tech from Teewinot 14-Jun-2016 By Gareth Macdonald Nemus Biosciences has licensed rights to an in-vitro synthetic cannabinoid manufacturing method developed by Teewinot Life Sciences.
Mystic awarded key manufacturing patent for delivery tech Mystic awarded key manufacturing patent for delivery tech 16-Jun-2011 Mystic Pharmaceuticals has been awarded a US patent for a manufacturing technology that is critical to its biologics delivery platform.
Patenting stem cells is 'ethical' Patenting stem cells is 'ethical' 09-Mar-2007 By Dr Matt Wilkinson A recent article published in the journal Stem Cell has advocated the patenting of isolated stem cell lines.
